Guideline Video

Guideline Resources

  • Weekly Medications Recap
  • June 8, 2026

Video Transcription

Welcome to another Medication Weekly Recap, here’s a quick rundown of medications approved by the FDA last week.

  • On May 8th, an expanded indication was approved for Hympavzi (marstacimab-hncq) to include the treatment of patients with hemophilia A or B 12 years and older with inhibitors and pediatric patients (ages 6 to 11 years) with or without inhibitors

And there you have it. For more information, check it out on guidelinecentral.com. See you next week for another weekly recap!

Sign up for alerts and stay informed on the latest published articles and guidelines.